Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.95
+0.05501.90%
Volume:154.80K
Turnover:454.59K
Market Cap:176.35M
PE:-3.95
High:3.09
Open:3.02
Low:2.86
Close:2.89
Loading ...
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2022

Major Issues Report

8-K - Current report
Jan 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 09, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Jul 02, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 14, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Major Issues Report

8-K - Current report
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 12, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]